Assessment of long‐term outcomes associated with urinary prostate cancer antigen 3 and TMPRSS2:ERG gene fusion at repeat biopsy

Publisher： John Wiley & Sons Inc

E-ISSN： 1097-0142|121|22|4071-4079

ISSN： 0008-543x

Source： CANCER, Vol.121, Iss.22, 2015-11, pp. : 4071-4079

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The TMPRSS2:ERG fusion and response to androgen deprivation therapy for prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 9, 2015-06 ,pp. : 897-906

John Wiley & Sons Inc

Access to resources Recommend Favorite

Association of ERG and TMPRSS2‐ERG with grade, stage, and prognosis of prostate cancer is dependent on their expression levels

By  

THE PROSTATE, Vol. 75, Iss. 11, 2015-08 ,pp. : 1216-1226

John Wiley & Sons Inc

Access to resources Recommend Favorite

Long-Term Outcomes in Patients with Prostate Cancer Managed with Intermittent Androgen Suppression

By  

Urologia Internationalis, Vol. 73, Iss. 2, 2004-08 ,pp. : 117-122

Karger

Access to resources Recommend Favorite

Long-Term Clinical Outcome of Diagnostic Transurethral Resection of the Prostate in Patients with Elevated Prostate-Specific Antigen Level and Minor Lower Urinary Tract Symptoms

By  

Urologia Internationalis, Vol. 83, Iss. 1, 2009-07 ,pp. : 60-65

Karger

Access to resources Recommend Favorite

Transrectal Ultrasound-Guided Prostate Biopsy for Cancer Detection: Performance of 2D-, 3D- and 3D-MRI Fusion Targeted Techniques

By  

Urologia Internationalis, Vol. 98, Iss. 1, 2016-10 ,pp. : 7-14

Karger

Access to resources Recommend Favorite